Global Medical Cannabis Market, by Route of Administration, 2018-2027

Growth Outlook

• The 2027 portion of the Global Medical Cannabis Market, by Route of Administration, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 28800 Mn in 2026 and is projected to reach USD 33210 Mn by 2027 — a gain of about 15% over the forecast period, translating to a CAGR in the double digits.
• The global medical cannabis market is rapidly expanding due to the growing acceptance and legalization of cannabis for medical purposes. The demand for medical cannabis is being driven by its various routes of administration, each of which offers unique benefits and advantages to patients.
• What the regional split looks like (2026): Inhalation leads, holding roughly 59% of segment value — the single largest regional share. Oral is the second-largest contributor. Topical make up the remainder, in descending order.
• By 2027, Inhalation alone is expected to reach USD 19538 Mn, with Oral at USD 9123 Mn.

Market Dynamics

The global medical cannabis market is rapidly expanding due to the growing acceptance and legalization of cannabis for medical purposes. The demand for medical cannabis is being driven by its various routes of administration, each of which offers unique benefits and advantages to patients. Oral administration is one of the most common routes of medical cannabis administration, as it is easy and convenient to consume. This route involves ingesting cannabis in various forms such as capsules, oils, and edibles. It is preferred by patients who do not want to smoke or inhale cannabis and those who are looking for a discreet way to consume it. Oral administration also allows for precise dosing, making it suitable for patients who require specific doses for their medical condition. Inhalation is another popular route of medical cannabis administration, particularly for patients who require quick relief from symptoms such as pain or nausea. This route involves smoking or vaporizing cannabis, which allows for rapid absorption into the bloodstream, resulting in fast-acting effects. Inhalation is also preferred by patients who have difficulty swallowing or have reduced gastrointestinal functioning.

Topical administration involves applying cannabis products directly onto the skin, where it is absorbed and provides localized relief for conditions such as arthritis and skin disorders. Topical cannabis products are available in the form of creams, lotions, balms, and patches, making it a convenient and non-invasive option for patients. Sublingual administration involves placing cannabis products under the tongue, where they are absorbed into the bloodstream through the tiny blood vessels in the mouth. This route is preferred by patients who want a quick onset of effects, as the cannabis is absorbed directly into the bloodstream without having to pass through the digestive system. The demand for medical cannabis is also fueled by the availability of multiple routes of administration, as it allows for individualized treatment plans based on patient preferences and needs. Furthermore, ongoing research and development in the medical cannabis industry are creating new and innovative routes of administration, such as nasal sprays and transdermal patches, which are expected to further drive the growth of the global medical cannabis market. In conclusion, the demand for medical cannabis is being driven by its various routes of administration, each offering distinct advantages and benefits to patients.

With the continuous evolution and advancement of medical cannabis products, the global medical cannabis market is expected to continue to grow and meet the increasing demand from patients worldwide.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.